On-Demand Upstream Manufacturing Webinars

1. Rethinking Starting Material: Whole Blood For Autologous T-Cell Manufacture 10/28/2026

   Matching starting material to process requirements in autologous T-cell manufacturing, and where whole blood may stand in for leukapheresis without compromising what the process needs.

2. Maintaining Process Consistency And Performance During Scale-Up 10/22/2026

   See how an intensified N-1 perfusion process maintained stable cultures, reproducible cell expansion, and aligned mAb production across 5 L, 50 L, and 500 L scales while supporting viable cell densities.

3. Maximize Exosome Yields Using a Chemically Defined Bioreactor Media System 10/22/2026

   See how scalable processes can improve exosome yield and recovery while maintaining critical quality attributes and supporting clinical manufacturing.

4. Intensifying Cell Production Processes Through Real-Time Control 10/14/2026

   Real-time lactate readings steering ATF perfusion automatically offer a route to denser, more scalable NK cell cultures while maintaining viability, a contrast with the limits of batch and fed-batch.

5. Beyond Fed-Batch: Choosing The Right Path To Process Intensification 10/6/2026

   Upstream intensification options, from concentrated fed-batch to N-stage perfusion, are weighed against organizational objectives, since no single technical strategy suits every framework.

6. Accelerating CHO Media Development: From Screening To AI Design 10/1/2026

   Discover how high-throughput screening, process analytics, and AI-guided modeling can help identify promising CHO media and feed combinations faster and support a more predictive approach.

7. Evaluating Modular CAR T Manufacturing Workflows 9/28/2026

   As CAR T manufacturing scales, balancing throughput, flexibility, and cell quality becomes increasingly complex. Explore strategies for improving process control, reducing bottlenecks, and more.

8. Challenges And Opportunities For MSC Expansion Workflows 9/22/2026

   Discover how optimizing cell culture platforms and closed systems reduces manufacturing costs, improves media efficiency, and supports scalable stem cell production.

9. Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production 9/15/2026

   Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.

10. Driving Productivity Across The Antibody Manufacturing Workflow 9/14/2026

    Learn how integrated upstream and downstream strategies can reduce harvest bottlenecks, improve purification efficiency, and support scalable therapeutic antibody manufacturing.